Term
what are some of the types of vaccine technology used? |
|
Definition
- inactivated whole virus
- inactivated whole bacteria
- live attenuated viral or bacterial vaccines
- conjugate vaccines: poorly immunogenic carbs conjugated to a carrier protein
- recombinant protein vaccines: cloned antigens expressed and purified in lab (ie: HepB)
- virus-like particles: capsid protein expressed in absence of other viral genes
|
|
|
Term
|
Definition
- immunopotentiators that enhance the immune responses to vaccines
- always licensed in combo with a specific vaccine
- alum is presently the only adjuvant licensed by the FDA for US vaccines
|
|
|
Term
what is the only adjuvant licensed in the US for vaccines? |
|
Definition
|
|
Term
what are the immune responses to vaccines? |
|
Definition
- serum Abs: mostly IgG
- secretory IgA (main Ab of the mucosa: respiratory, GI, GU tracts)
- cell mediated immunity stimulated
|
|
|
Term
what are the components of the immunological memory triggered by vaccination? |
|
Definition
- accelerated immune response upon pathogen exposure
- enhanced immune response
- higher affinity Abs vs naive subject response
- long lived B and T memory cells elicited
|
|
|
Term
how does the immune response differe between PS and a PS-protein conjugate vaccine? |
|
Definition
in PS vaccine:
- PS binds BCR stimulating differentiation into plasma cell, which secretes low affinity IgG2 and IgM
- no production of memory cells
- no recruitment of T cells: T CELL INDEP'T
in PS-protein conjugate vaccine:
- bacteria antigen binds BCR
- protein component taken up, digested, and displayed on MHC class II peptide for T cell stimulation
- B cell expresses CD40R which binds T cell CD40L for further downstream activation of B cell
- B cell expresses B7 (CD80/CD86) (costimulatory ligand) that binds CD28 receptor on T cell
- PS specific memory cells are produced
- differentiated plasma cell produces higher affinity IgG1 and IgG3
|
|
|
Term
what are examples of licensed conjugate vaccines in the US? |
|
Definition
- Hib: capsular PS conjugated to carrier protein of tetantus toxoid derivation (PRP-T)
- Streptococcus pneumoniae + mutant tetanus toxoid protein
- Neisseria meningitis conjugated to diptheria toxoid
|
|
|
Term
what are some important considerations for vaccines and the potential range of immune responses? |
|
Definition
- age: elderly/infants immune response weaker
- route of administration: parenteral (im, sc, etc) vs mucosal (oral, intranasal)
- genetic makeup of host
- environmental effetcs on host
- varying response to parental (higher in developing) vs oral (higher in industrialized) vaccines in developing vs industrialized nations
|
|
|
Term
how do serum Abs ward off infection? |
|
Definition
- bind to antigen
- neutralization of viruses (measles, yellow fvr)
- neutralizationof toxins (tetanus, diphtheria, cholera)
- complement mediated bactericidal killing
- opsonophagocytic killing
- Ab dept cellular cytotoxicity (ADCC): often mediated by NKs
|
|
|
Term
how do mucosal Abs ward off infection? |
|
Definition
- prevent attachment of pathogens to mucosal surface
- neutralize toxins
- intracellular neutralization of viruses
|
|
|
Term
what is the mechanism of action of the attenuated measles virus vaccine? |
|
Definition
- sc administration
- elicits serum plaque reduction neutralizing (PRN) Abs that bind Hemagglutinin (H) protein by which virus binds to receptors on cells
- stimulates CMI via CD8+ cells
- effective when administered as small particle aerosal in pts > 10mos
- ineffective as large nasal droplets
|
|
|
Term
where in the body does oral immunization induce response? |
|
Definition
- proximal small intestine
- ascending colon
- mammary and salivary glands
|
|
|
Term
where in the body does rectal immunization induce response? |
|
Definition
|
|
Term
where in the body does nasal or tonsillar immunization induce response? |
|
Definition
- upper airway mucosa
- saliva, nasal secretions
- female genital tract (vagina, cervix)
|
|
|
Term
why is an adjuvant an attractive option for H1N1 vaccine? |
|
Definition
- dose sparing: may be able to immunize with low doses of vaccine
- single dose regimen: may be able to achieve protective titers in non-elderly adults with 1 dose of adjuvanted vaccine
|
|
|
Term
what are the qualities of an "ideal" vaccine? |
|
Definition
- safe in all ages and immunocompromised
- efficacious in all ages, incl young and old
- single dose
- protection early and long lasting
- adminstrable w/o needle and syringe
- no cold chain needed
- combinable w other vaccines
|
|
|
Term
what 2 broad considerations must be balanced with vaccine developed? |
|
Definition
immunogenicity and reactogenicity
powerful stimulation of the innate immune system, accompanied by release of various cytokines often results in fever, malaise, other adverse effects |
|
|
Term
what are some obstacles to vaccination? |
|
Definition
- funds
- cold chain
- poor infrastructure
- poor acceptance
|
|
|